Miragen Therapeutics, Inc.

Home » Miragen Therapeutics, Inc.

IPO

Miragen Therapeutics, Inc.

They are a clinical-stage biopharmaceutical company discovering and developing proprietary RNA-targeted therapeutics with a specific focus on microRNAs and their roles in diseases where there is a high unmet medical need.

Symbol

MGEN

Price Range
$8.60 - $6.52

Anticipated Shares
7,000,000

Effective Date
February 9, 2018

Underwriters
Jefferies, Evercore ISI, Deutsche Bank

To view the prospectus for Miragen Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253